https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=United_Therapeutics_Corporation 2026-05-01T04:01:22Z Istoricul versiunilor pentru această pagină din wiki MediaWiki 1.39.2 https://wiki.tradeville.ro/index.php?title=United_Therapeutics_Corporation&diff=1804&oldid=prev 2023-04-21T13:30:47Z

<p>csv2wiki</p> <p><b>Pagină nouă</b></p><div> <br /> Pagina dedicata companiei United Therapeutics Corporation listata cu simbolul US.UTHR<br /> <br /> ==Descriere companie==<br /> United Therapeutics Corporation (http://www.unither.com) is a biotechnology company. The Company is focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The Company market and sell four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution, which includes the Tyvaso Inhalation System; Orenitram (treprostinil) Extended-Release Tablets; and Adcirca (tadalafil) Tablets. In the United States, the Company also markets and sells an oncology product, Unituxin (dinutuximab) Injection, which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion.<br /> <br /> <br /> ==Ultimele stiri despre United Therapeutics Corporation (US.UTHR)==<br /> &lt;dynamicpagelist&gt;<br /> category=US.UTHR<br /> count=10<br /> order=descending<br /> addfirstcategorydate=false<br /> &lt;/dynamicpagelist&gt;<br /> [[Categorie:US.UTHR]][[Categorie:Stiri despre companii]]</div>

Admin